23 Jul, 2026
According to Straits Research, the global constipation treatment market size was valued at $9.68 billion in 2025 and is projected to grow from $10.26 billion in 2026 to $16.46 billion by 2034, registering a CAGR of 6.09% during the forecast period 2026–2034.
Constipation is a common gastrointestinal problem marked by irregular bowel motions, difficulty passing stool, and discomfort. Constipation treatment includes several treatments and strategies for relieving and managing constipation symptoms. The treatment for constipation is determined by the severity of the condition and the underlying causes.
High Prevalence of Constipation Fuels the Global Market
People of all ages suffer from constipation. Constipation affects newborns and adults. The Journal of Pediatric Gastroenterology and Nutrition reported in 2019 that up to 30% of Western children had constipation. Constipation is so common that therapies and treatments that relieve symptoms are in high demand. The National Library of Medicine predicts that 14% of the world will have chronic constipation. Thus, the increasing prevalence of constipation drives the market for treatments and therapies to address it. The market grows to meet the demands of constipated people of all ages as constipation remains a global health issue.
Innovative Treatments Creates Tremendous Opportunities
Novel constipation treatments provide significant market growth potential. Constipation treatment market trends will differ. These advances aim to improve therapy efficacy, safety, and patient comfort. Biologic treatments targeting constipation-related molecules or receptors are being developed. These treatments aim for precision and safety. Research and development in biologics continue. These medicines could revolutionize constipation therapy if they pass clinical studies. Innovative constipation treatments improve patient results and quality of life. Innovative constipation therapies can make companies market leaders in gastrointestinal healthcare. Innovative constipation treatments stimulate research and development spending, helping patients and the healthcare industry.
North America is expected to dominate worldwide due to rising chronic constipation and healthcare investment. Americans of all ages and demographics suffer from constipation, according to December 2021 NIDDK statistics. About 16 per 100 people have constipation. Seniors have 33 constipation cases per 100. Demand for effective treatments will rise as constipation becomes more common, driving the investigated market. Due to its many constipation drug makers, the U.S. has the biggest North American market share. Constipation is expected to rise with chronic pain problems and painkiller use. Therefore, these factors boost market growth.
According to the U.S. Pain Foundation, 2022 research, 50 million Americans have chronic pain, and 47% take opioids, boosting the market growth. Increased regulatory approval of opioid-induced constipation (OIC) medicines will drive market expansion. The Agency for Healthcare Research and Quality predicts that the U.S. government spends USD 560–USD 635 billion on pain drugs, which might boost the constipation treatment industry.
The Asia-Pacific constipation treatment market is expected to grow due to rising constipation and the prevalence of geriatrics during the forecast period. China, a regional powerhouse, has a large constipation treatment market. Changing lifestyles and an older population drive constipation treatment needs. Asia-Pacific healthcare ranges from developed systems in Japan and Australia to emerging markets in Southeast Asia. Diversity affects constipation treatment availability and accessibility. A 2022 Pace Hospital survey found that 20% of adults and 29.6% of children suffer from constipation. Constipation affects seniors more than younger people. Acute constipation affects older women two to three times more than males. Constipation affects 22% of Indian adults, with 59% experiencing acute constipation and 27% experiencing comorbidities.
sales@straitsresearch.com